TY - DATA T1 - Effects of CYSKT on the levels of HbA1c and blood glucose in type 2 diabetic mice. PY - 2014/08/18 AU - Hsin-Yi Lo AU - Chien-Yun Hsiang AU - Tsai-Chung Li AU - Chia-Cheng Li AU - Hui-Chi Huang AU - Jaw-Chyun Chen AU - Tin-Yun Ho UR - https://plos.figshare.com/articles/figure/_Effects_of_CYSKT_on_the_levels_of_HbA1c_and_blood_glucose_in_type_2_diabetic_mice_/1143673 DO - 10.1371/journal.pone.0104650.g001 L4 - https://ndownloader.figshare.com/files/1641181 KW - phosphorylated insulin receptor KW - blood glucose levels KW - HbA 1c values KW - CYSKT KW - novel HbA 1c formula KW - type 2 KW - glucose transporter 4. KW - Chinese Medicinal Formula KW - blood glucose clearance KW - fasting blood glucose KW - Taiwan Diabetic Care Management Program KW - Translational Medicine Study Diabetes KW - HbA 1c KW - translational medicine study KW - health care system KW - Novel Glycated Hemoglobin N2 - Type 2 diabetic mice were administered orally 200 mg/kg CYSKT for 30 consecutive days. Blood samples were collected every 10 days and measured for HbA1c levels (A) and fasting blood glucose levels (B). Glucose tolerance test was performed on 30th day after CYSKT administration. Mice were fasted for 4 h, glucose (1 g/kg) was injected intraperitoneally, and the blood glucose levels at intervals were measured (C). Values are mean ± SD (n = 5). *p<0.05, **p<0.01, ***p<0.001, compared with mock. ER -